Transplant Recipient Registration (TRR) records are generated and available immediately after a transplant event is reported through the recipient feedback process in WaitlistSM. Forms are generated by the age at transplant, not the age at listing. The TRR record is completed by the transplant center performing the transplant. The registration and hospital discharge follow-up information is combined in this record.
Complete the TRR at hospital discharge or six weeks post transplant, whichever is first. If the recipient is still hospitalized at six weeks post transplant, provide data regarding the recipient’s progress consistent with the six-week time frame.
The TRR must be validated within 90 days of the record generation date. Example: If the recipient is removed as being transplanted on 10/1/XXXX, the TRR form will be due 90 days from that date, 12/30/XXXX. See OPTN Policies for additional information. Use the search feature to locate specific policy information on Data Submission Requirements.
To correct information that is already displayed on an electronic record, call the UNetSM Help Desk at 1-800-978-4334.
Additional Resources: See History of Definition Changes.
Recipient Information
Name: Verify the last name, first name and middle initial of the transplant recipient is correct. If the information is incorrect, corrections may be made on the recipient's TCR record.
DOB: Verify the displayed date is the recipient's date of birth. If the information is incorrect, corrections may be made on the recipient's TCR record.
SSN: Verify the recipient's social security number is correct. If the information is incorrect, contact the Help Desk at 1-800-978-4334.
Gender: Verify the recipient's gender is correct. If the information is incorrect, corrections may be made on the recipient's TCR record.
HIC: Verify the 9 to 11 character Health Insurance Claim number for the recipient indicated on the recipient's most recently updated TCR record is correct. If the recipient does not have a HIC number, you may leave this field blank.
Tx Date: Verify that the displayed transplant date is correct. The transplant date is determined by the start of the organ anastomosis during transplant or the start of the islet infusion. Organ transplants include solid organ transplants and islet infusions. An organ transplant procedure is complete when any of the following occurs:
The chest or abdominal cavity is closed and the final skin stitch or staple is applied.
The transplant recipient leaves the operating room, even if the chest or abdominal cavity cannot be closed.
The islet infusion is complete.
State of Permanent Residence: Select the name of the state of the recipient's permanent address at the time of transplant (location of full-time residence, not transplant center location). This field is required. (List of State codes)
Permanent Zip Code: Enter the recipient's permanent zip code at the time of transplant (location of full-time residence, not transplant center location). This field is required.
Provider Information
Recipient Center: The Recipient Center information reported in Waitlist displays. Verify that the center information is the hospital where the transplant operation was performed. The Provider Number is the 6-character Medicare identification number of the hospital. This is followed by the Center Code and Center Name.
Surgeon Name: Enter the name of the primary surgeon, who performed the transplant operation, and under whose name the transplant is billed. This field is required.
NPI #: Enter the 10-character CMS (Center for Medicare and Medicaid Services) assigned National Provider Identifier of the transplant surgeon. Your hospital billing office may be able to obtain this number for you. This field is required.
Donor Information
UNOS Donor ID #: The donor ID number, reported in the Recipient Feedback, will display. Each potential donor is assigned an identification number by the OPTN. This ID number corresponds to the date the donor information was entered into the OPTN computer system.
Recovering OPO: The Organ Procurement Organization (OPO) code will display. Verify the code is correct.
Donor Type: The donor type, reported in the Recipient Feedback, will display. Verify the recipient's donor type is correct. If the information is incorrect, contact the Help Desk at 1-800-978-4334.
Deceased
indicates the donor was not living at the time of donation.
Living
indicates the donor was living at the time of donation.
Patient Status
Primary Diagnosis: Select the primary diagnosis for the disease requiring a transplant for this recipient. If the recipient has had a previous transplant for the same organ type, enter Retransplant/Graft Failure as the primary diagnosis for that organ. If Other, Specify is selected, enter the primary diagnosis in the space provided. The primary diagnosis should not be changed to concur with the pathology confirmed diagnosis. The primary diagnosis field should reflect information known at the time of transplant. This field is required. (List of Pancreas Diagnosis codes)
Date: Last Seen, Retransplanted or Death: Complete at discharge (if discharged prior to six weeks from transplant date) or at six weeks from transplant date, whichever occurs first. Enter the date the hospital reported the recipient as living, retransplanted (when the data was obtained prior to the recipient's discharge) or the date of the recipient's death, using the standard 8-digit numeric format of MM/DD/YYYY. This field is required.
Patient Status: Complete at discharge (if discharged prior to six weeks from transplant date) or at six weeks from transplant date, whichever occurs first. Select the appropriate status for this recipient. If Dead is selected, indicate the cause of death. This field is required.
Living
Dead
Retransplanted
Primary Cause of Death: If the Patient Status is Dead, select the patient's cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Primary Cause of Death codes)
Contributory Cause of Death: If the Patient Status is Dead, select the patient's contributory cause of death. Do not select the primary cause, since it cannot be both the primary and contributory cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Contributory Cause of Death codes)
Contributory Cause of Death: If the Patient Status is Dead, select the patient's contributory cause of death. Do not select the primary cause, since it cannot be both the primary and contributory cause of death. If an Other code is selected, enter the other cause of death in the space provided. (List of Contributory Cause of Death codes)
Note: If the Patient Status is Retransplanted, then Failed must be selected for the Pancreas Graft Status.
Note: If the patient is being retransplanted, access the patient's last record for their previous transplant and select Retransplanted in the Patient Status field. This will stop the generation of TRF records associated with the previous transplant.
Transplant Hospitalization:
Date of Admission to Tx Center: Enter the date the recipient was admitted to the transplant center, using the standard 8-digit MM/DD/YYYY format. If the patient was admitted to the hospital before it was determined a transplant was needed, enter the date it was determined the patient needed a transplant. This field is required.
Date of Discharge from Tx Center: Enter the date the recipient was released to go home, using the standard 8-digit MM/DD/YYYY format. The recipient's hospital stay includes total time spent in different units of the hospital, including medical and rehab. This information is not required in the TRR record, but if entered here, it will automatically fill in the future TRF records. It is required in the TRF record.
Note: Leave this field blank if the recipient was removed from the waiting list with a code of 21, indicating the recipient died during the transplant procedure.
Clinical Information: PRETRANSPLANT
Functional Status: Select the choice that best describes the recipient's functional status just prior to the time of transplant. This field is required.
Note: The Karnofsky Index will display for adults aged 18 and older.
100% - Normal, no complaints, no evidence of disease
90% - Able to carry on normal activity: minor symptoms of disease
80% - Normal activity with effort: some symptoms of disease
70% - Cares for self: unable to carry on normal activity or active work
60% - Requires occasional assistance but is able to care for needs
50% - Requires considerable assistance and frequent medical care
40% - Disabled: requires special care and assistance
30% - Severely disabled: hospitalization is indicated, death not imminent
20% - Very sick, hospitalization necessary: active treatment necessary
10% - Moribund, fatal processes progressing rapidly
Note: The Lansky Score will display for pediatrics aged less than 18.
100% - Fully active, normal
90% - Minor restrictions in physically strenuous activity
80% - Active, but tires more quickly
70% - Both greater restriction of and less time spent in play activity
60% - Up and around, but minimal active play; keeps busy with quieter activities
50% - Can dress but lies around much of day; no active play; can take part in quiet play/activities
40% - Mostly in bed; participates in quiet activities
30% - In bed; needs assistance even for quiet play
20% - Often sleeping; play entirely limited to very passive activities
10% - No play; does not get out of bed
Not Applicable (patient < 1 year old)
Unknown
Note: This evaluation should be in comparison to the person's normal function, indicating how the patient's disease has affected their normal function.
Cognitive Development: (This field is required for recipients 18 years of age or younger.) Select the choice that best describes the recipient's cognitive development just prior to the time of transplant.
Definite Cognitive Delay/Impairment (verified by IQ score <70 or unambiguous behavioral observation)
Probable Cognitive Delay/Impairment (not verified or unambiguous but more likely than not, based on behavioral observation or other evidence)
Questionable Cognitive Delay/Impairment (not judged to be more likely than not, but with some indication of cognitive delay/impairment such as expressive/receptive language and/or learning difficulties)
No Cognitive Delay/Impairment (no obvious indicators of cognitive delay/impairment)
Not Assessed
Motor Development: (This field is required for recipients 18 years of age or younger.) Select the choice that best describes the recipient's motor development just prior to the time of transplant.
Definite Motor Delay/Impairment (verified by physical exam or unambiguous behavioral observation)
Probable Motor Delay/Impairment (not verified or unambiguous but more likely than not, based on behavioral observation or other evidence)
Questionable Motor Delay/Impairment (not judged to be more likely than not, but with some indication of motor delay/impairment)
No Motor Delay/Impairment (no obvious indicators of motor delay/impairment)
Not Assessed
Academic Progress: (This field is required for recipients less than 18 years of age.) Select the choice that best describes the recipient's academic progress just prior to the time of transplant. If the recipient is less than 5 years old or has graduated from high school, select Not Applicable < 5 years old/High School graduate or GED.
Within
One Grade Level of Peers
Delayed Grade Level
Special
Education
Not Applicable <5 years old/High School graduate or
GED
Status Unknown
Academic Activity Level: (This field is required for recipients less than 18 years of age.) Select the choice that best describes the recipient's academic activity level just prior to the time of transplant. If the recipient is less than 5 years old or has graduated from high school, select Not Applicable < 5 years old/High School graduate or GED.
Full
academic load
Reduced academic load
Unable to participate
in academics due to disease or condition
Not Applicable <5
years old/High School graduate or GED
Status Unknown
Working for income: (This field is required for recipients 18 years of age or older.) If the recipient is working for income just prior to the time of transplant, select Yes. If not, select No. If unknown, select UNK.
Source of Payment:
Primary: Select as appropriate to indicate the recipient's source of primary payment (largest contributor) for the transplant. This field is required. (List of Primary Insurance codes)
Private insurance refers to funds from agencies such as Blue Cross/Blue Shield, etc. It also refers to any worker's compensation that is covered by a private insurer.
Public insurance - Medicaid refers to state Medicaid funds.
Public insurance - Medicare FFS (Fee-for-Service) refers to funds from the government in which doctors and other health care providers are paid for each service provided to a recipient. Includes Medicare part A, part B and part D. Medicare part A (hospital) must be in place to be considered primary payer. For additional information about Medicare, see http://www.medicare.gov/.
Public insurance - Medicare & Choice (also known as Medicare Managed Care) refers to funds from the government in which doctors and other health care providers are paid for each service provided to a recipient, along with additional benefits such as coordination of care or reducing-out-of-pocket expenses. Sometimes a recipient may receive additional benefits such as prescription drugs. For additional information about Medicare, see http://www.medicare.gov/.
Public insurance - CHIP (Children's Health Insurance Program)
Public insurance - Department of VA refers to funds from the Veterans Administration.
Public insurance - Other government
Self indicates that the recipient will pay for the cost of transplant.
Donation indicates that a company, institution, or individual(s) donated funds to pay for the transplant and care of the recipient.
Free Care indicates that the transplant hospital will not charge recipient for the costs of the transplant operation.
Foreign Government, Specify refers to funds provided by a foreign government (Primary only) Specify foreign country in the space provided. (List of Foreign Country codes)
Unknown
Date of Measurement: (Complete for recipients 18 years of age or younger.) Enter the date, using the 8-digit format of MM/DD/YYYY, the recipient’s height and weight were measured.
Height: Enter the height of the recipient, just prior to the time of transplant, in feet and inches or centimeters. If the recipient’s height is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). (List of Status codes) For recipients 18 years old or younger at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts. This field is required.
Weight: Enter the weight of the recipient, just prior to the time of transplant, in pounds or kilograms. If the recipient’s weight is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). (List of Status codes) For recipients 18 years old or younger at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts. This field is required.
BMI (Body Mass Index): The recipient's BMI will display. For candidates less than 20 years of age at the time of transplant, UNet will generate and display calculated percentiles based on the 2000 CDC growth charts.
Percentiles are the most commonly used clinical indicator to assess the size and growth patterns of individual children in the United States. Percentiles rank the position of an individual by indicating what percent of the reference population the individual would equal or exceed (i.e. on the weight-for-age growth charts, a 5 year-old girl whose weight is at the 25th percentile, weighs the same or more than 25 percent of the reference population of 5-year-old girls, and weighs less than 75 percent of the 5-year-old girls in the reference population). For additional information about CDC growth charts, see http://www.cdc.gov/.
Note: Users who check the BMI percentiles against the CDC calculator may notice a discrepancy that is caused by the CDC calculator using 1 decimal place for height and weight and UNet using 4 decimal places for weight and 2 for height.
Previous Transplants: The three most recent transplant(s), indicated on the recipient's validated Transplant Recipient Registration (TRR) record(s), will display. Verify all previous transplants listed by organ type, transplant date and graft failure date.
Note: The three most recent transplants on record for this recipient will be displayed for verification. If there are any prior transplants that are not listed here, contact the UNet Help Desk at 1-800-978-4334 or unethelpdesk@unos.org to determine if the transplant event is in the database.
Pretransplant Dialysis: If the recipient was on maintenance dialysis before transplant, select Yes. If not, select No. If unknown, select UNK. This field is required.
If Yes, Date of Most Recent Initiation of Chronic Maintenance Dialysis: If the recipient was on maintenance dialysis before transplant, enter the date of most recent initiation of chronic maintenance dialysis. If the date is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). (List of Status codes)
Average Daily Insulin Units: Enter the average daily total insulin dosage units in the space provided. Average daily insulin dose should be a total including all insulin administered in any form per day (short term, long term, by pump, subcutaneous). The insulin dosage units must be between 1 and 1000. If the value is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required.
Serum Creatinine at Time of TX: Enter the serum creatinine at the time of transplant in mg/dl. If the value is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required.
Viral Detection:
HIV Serostatus: Select the serology results from the list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: (Human Immunodeficiency Virus) - The virus that causes AIDS, which is the most advanced stage of HIV infection. HIV is a retrovirus that occurs as two types: HIV-1 and HIV-2. Both types are transmitted through direct contact with HIV-infected body fluids, such as blood, semen, and genital secretions, or from an HIV-infected mother to her child during pregnancy, birth, or breastfeeding (through breast milk).
CMV Status: Select the serology results from the list. If there is a positive CMV IgG or positive CMV Total Antibody result then CMV Status should be reported as positive. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: Cytomegalovirus - A herpesvirus (genus Cytomegalovirus) that causes cellular enlargement and formation of eosinophilic inclusion bodies especially in the nucleus and that acts as an opportunistic infectious agent in immunosuppressed conditions (as AIDS).
HBV Surface Antibody Total: Select the serology results from the list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
HBV Core Antibody: Select the serology results from the list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: Hepatitis B Virus - A sometimes fatal hepatitis caused by a double-stranded DNA virus (genus Orthohepadnavirus of the family Hepadnaviridae) that tends to persist in the blood serum and is transmitted especially by contact with infected blood (as by transfusion or by sharing contaminated needles in illicit intravenous drug use) or by contact with other infected bodily fluids (as during sexual intercourse) -- also called serum hepatitis.
HBV Surface Antigen: Select the serology results from the list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: Hepatitis B Virus - A sometimes fatal hepatitis caused by a double-stranded DNA virus (genus Orthohepadnavirus of the family Hepadnaviridae) that tends to persist in the blood serum and is transmitted especially by contact with infected blood (as by transfusion or by sharing contaminated needles in illicit intravenous drug use) or by contact with other infected bodily fluids (as during sexual intercourse) -- also called serum hepatitis.
HCV Serostatus: Select the serology results from the list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: Hepatitis C Virus - A disease caused by a flavivirus that is usually transmitted by parenteral means (as injection of an illicit drug, blood transfusion, or exposure to blood or blood products) and that accounts for most cases of non-A, non-B hepatitis.
EBV Serostatus: Select the serology results from the list. If there is a positive EBV IgG or positive EBV Total Antibody result then EBV Serostatus should be reported as positive. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: (Epstein-Barr Virus) - A herpesvirus (genus Lymphocryptovirus) that causes infectious mononucleosis and is associated with Burkitt's lymphoma and nasopharyngeal carcinoma -- abbreviation EBV; called also EB virus.
NAT (Nucleic Acid Test) Results:
HIV NAT: Select the NAT results from the list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: (Human Immunodeficiency Virus) - The virus that causes AIDS, which is the most advanced stage of HIV infection. HIV is a retrovirus that occurs as two types: HIV-1 and HIV-2. Both types are transmitted through direct contact with HIV-infected body fluids, such as blood, semen, and genital secretions, or from an HIV-infected mother to her child during pregnancy, birth, or breastfeeding (through breast milk).
HBV NAT: Select the NAT results from the list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: (Hepatitis B Virus) - A virus which primarily causes inflammation of the liver. The hepatitis B virus can be transmitted in several ways including blood transfusion, needle sticks, body piercing and tattooing using unsterile instruments, dialysis, sexual and even less intimate close contact, and childbirth. Symptoms include fatigue, jaundice, nausea, vomiting, dark urine, and light stools.
HCV NAT: Select the NAT results from the list. This field is required.
Positive
Negative
Not
Done
UNK/Cannot Disclose
Definition: (Hepatitis C Virus) - Inflammation of the liver due to the hepatitis C virus which is usually spread via blood transfusion (rare), hemodialysis, and needle sticks. The damage hepatitis C does to the liver can lead to cirrhosis and its complications as well as cancer. Transmission of the virus by sexual contact is rare. At least half of hepatitis C patients develop chronic hepatitis C infection. Diagnosis is made by blood test. Treatment and probably cure is via antiviral drugs and is effective in over 90% of patients. Chronic hepatitis C was frequently treated with injectable interferon, in combination with antiviral oral medications, but now is most often treated with oral antivirals alone.
Note: For an equivocal (or indeterminate) result that changes to either positive or negative, change the result to the newer more specific value even though it may be a different test date. For a result that was originally equivocal (or indeterminate) or remains equivocal (or indeterminate) after repeated testing, record as “UNK/cannot disclose".
Malignancies between listing and transplant: If recipient had any malignancies between listing and transplant, select Yes. If the recipient has not had any malignancies, select No. If Yes is selected, indicate type of malignancy. If unknown, select UNK. If the recipient had a malignancy, but the type of malignancy is not listed, select Other, specify and enter the name of the malignancy in the space provided. This field is required.
Skin
Melanoma
Skin Non-Melanoma
CNS
Tumor
Genitourinary
Breast
Thyroid
Tongue/Throat/Larynx
Lung
Leukemia/Lymphoma
Liver
Other,
specify
Note: This question is NOT applicable for patients receiving living donor transplants who were never on the waiting list.
Clinical Information: TRANSPLANT PROCEDURE
Multiple Organ Recipient: If the recipient received other organs, reported on the Recipient Feedback, they will display. If the recipient didn't receive any other organs at this time, None is displayed. Verify the other organs, transplanted at this time, are correct. If incorrect, contact the Help Desk.
Were extra vessels used in the transplant procedure: If extra vessels (vascular allografts) were used in the transplant procedure, as indicated on the Waitlist Removal, YES displays.
Vessel Donor ID: The Donor ID entered on the WaitlistSM Removal displays. Donor IDs entered for this question must be from deceased donors. All deceased donor extra vessels must be monitored due to the potential for disease transmission.
Note: If the extra vessels used in a transplant procedure are procured from a tissue processing organization, they are not reported in UNet.
Procedure Type: The procedure type, reported in the Recipient Feedback, will display. Verify the information displayed in the Procedure Type field is correct.
LEFT KIDNEY
RIGHT KIDNEY
EN-BLOC
Sequential Kidney
Pancreas Segment
Whole Pancreas with Duodenum
Whole Pancreas with Duodenal Patch
Whole Pancreas
Pancreas segment / Kidney Right
Pancreas segment / Kidney Left
Pancreas segment / En-bloc Kidney
Pancreas Segment/Sequential Kidney
Whole pancreas with duodenum / left kidney
Whole pancreas with duodenum / right kidney
Whole pancreas with duodenum / en-bloc kidneys
Pancreas with duodenum/sequential kidney
Whole pancreas with duodenal patch / left kidney
Whole pancreas with duodenal patch / right kidney
Whole pancreas with duodenal patch / en-bloc kidneys
Pancreas with duodenal patch/sequential kidney
Whole pancreas / left kidney
Whole pancreas / right kidney
Whole pancreas / en-bloc kidneys
Whole pancreas/sequential kidney
Surgical Information:
Graft Placement: Indicate where the graft was placed during the transplant operation. This field is required.
Intra-Peritoneal:
Pancreas graft placed totally within the peritoneal
cavity.
Retro-Peritoneal:
Pancreas graft placed totally behind the peritoneum (extra
peritoneal).
Partial
Intra/Retro-Peritoneal:
Pancreas placed retroperitoneally with the peritoneum then opened.
Operative Technique: Indicate the type of pancreas transplant. This field is required. (List of Operative Technique codes)
Pancreas
Alone: The
recipient only received a pancreas.
Cluster:
The recipient received a pancreas with a least a whole liver. Other
organs could also have been transplanted.
Multi-Organ
Non-Cluster: The
recipient received a pancreas with any other organ(s) excluding
kidney and liver.
Pancreas
After Kidney: The
recipient received a pancreas after having a kidney transplant in the
past.
Pancreas
with Kidney Different Donor: The
recipient received a deceased donor pancreas in addition to a living
donor kidney at the same time.
Duct Management: Indicate the type of duct management used to manage the exocrine pancreatic functions. This field is required. (List of Duct Management codes)
Enteric
with Roux-En-Y: The
pancreatic duct is allowed to drain into the small intestine using a
Roux-En-Y.
Enteric
without Roux-En-Y:
The pancreatic duct is allowed to drain into the small intestine
without using a Roux-En-Y.
Cystostomy:
The pancreatic duct is allowed to drain into the bladder.
Duct
Injection Immediate:
A synthetic polymer is injected directly into the pancreatic duct
immediately after surgical revascularization.
Duct
Injection Delayed:
The duct is left open for a period up to 30 days before a synthetic
polymer is injected directly into the pancreatic duct.
Other
Specify: If a type
of duct management used is not listed, select Other
and enter the type of duct management in the space provided.
Note: If it is a multi-visceral transplant, select Enteric with Roux-En-Y or Enteric without Roux-En-Y. Only when either of these is selected will you have the N/A option on the Pancreas Transplant Recipient Follow-up (TRF) Record for Conv. From Bladder to Enteric Drain Performed.
Venous Vascular Management: Indicate which venous system (systemic or portal) was used to attach the pancreas. This field is required. (List of Vascular Management codes)
Systemic
System (Iliac:Cava)
Portal System (Portal or
Tributaries)
NA/Multi-organ cluster
Arterial Reconstruction: Indicate the type of arterial reconstruction used in the transplant operation. This field is required. (List of Arterial Reconstruction codes)
Celiac Axis with Pancreas: The celiac axis remained attached to the pancreas and reconstruction of the artery was not necessary.
Y-Graft to SpA and SMA: The splenic artery (SpA) and the superior mesenteric artery (SMA) were attached via an arterial graft.
SpA to SMA Direct: The splenic artery was anastomosed end-to-side to the superior mesenteric artery.
SpA to SMA with Interposition: The splenic artery was attached to the superior mesenteric artery with an interposition graft.
SpA Alone: The splenic artery alone.
Other Specify: If the type of arterial reconstruction is not listed, select Other and enter the type of reconstruction used in the space provided.
Venous Extension Graft: If a venous extension graft was used to lengthen the portal or splenic vein of the pancreas graft, select Yes. If not, select No. This field is required.
Preservation Information:
The preservation information for the pancreas procedure type is displayed for the recipient. Enter the Total Pancreas Preservation Time, in hours, for the pancreas procedure.
Total Pancreas Preservation Time (include cold, warm and anastomotic time) is the time between cessation of blood flow in the donor and revascularization of the pancreas in the recipient. If the time is unavailable, select the appropriate status from the ST field (Missing, Unknown, N/A, Not Done). This field is required. (List of Status codes)
Note: Enter the time in hours and decimal parts of an hour. For example, 1 hour should be entered as "1", "1.0" or "1.00"; 1 hour and 30 minutes should be entered as "1.5" or "1.50" not "1.30". To report the minutes, divide the number of minutes into 60 and record 2 decimal places. Example: 7hrs 19 minutes = 7.32 ( 60 divided by 19 =.32)
Clinical Information: POST TRANSPLANT
Pancreas Graft Status: Select the status that best describes the pancreas graft status. If the Patient Status is Retransplanted for the pancreas, this field is not applicable.
Note: If death is indicated for the recipient, report graft status up until the instance of death.
Functioning: The graft has sufficient function so that the recipient is NOT receiving a level of insulin for blood sugar control that constitutes a failed graft (0.5 kg of insulin a day for 90 consecutive days).
Failed: The graft has failed when ANY of the following occurs:
· A recipient’s transplanted pancreas is removed
· A recipient re-registers for a pancreas
· A recipient registers for an islet transplant after receiving a pancreas transplant
· A recipient’s insulin use is greater than or equal to 0.5 units/kg/day for a consecutive 90 days
· A recipient dies
If Failed is selected, complete the following fields:
Pancreas Date of Failure: Enter the date of failure using the standard 8 digit numeric format of MM/DD/YYYY. If the Patient Status is Retransplanted for the pancreas, this field is not applicable.
Pancreas Graft Removed: If the pancreas graft had been removed, select Yes. If not, select No. If unknown, select UNK.
If Yes, Date Pancreas Graft Removed: If the pancreas graft had been removed, enter the date of removal.
Pancreas Primary Cause of Graft Failure: Select the primary cause of graft failure. If the primary cause of graft failure is not listed, select Other Specify and enter the primary cause of graft failure in the space provided.
Graft/Vascular
Thrombosis
Infection
Bleeding
Anastomotic Leak
Primary
Non-Function
Acute Rejection
Hyperacute Rejection
Biopsy
Proven Isletitis
Pancreatitis
Other Specify
Contributory causes of graft failure: For each of the causes listed, select Yes, No, or UNK to indicate whether each is a contributory cause of graft failure. Select NO for the primary cause, since it cannot be both the primary and secondary cause of graft failure. If Other is selected, specify the cause in the space provided.
Pancreas
Graft/Vascular Thrombosis
Pancreas
Infection
Bleeding
Anastomotic Leak
Hyperacute
Rejection
Pancreas Acute Rejection
Biopsy Proven
Isletits
Pancreatitis
Other Specify
Patient using either oral medication or diet for blood sugar control: Answer whether the patient is using diet or medication for blood sugar control, not including insulin. This includes injectable, non-insulin medications. Select Yes, No, or UNK to indicate whether the patient is using any method of blood sugar control. This field is required.
Note: The intent of this field is to collect data on prescribed blood sugar maintenance. Extraneous methods sought out by a recipient outside of the prescribed regimen should not be taken into account when reporting on known methods of blood sugar control. For example, if it is known that a recipient is not on oral medication for blood sugar control, but it is unknown whether a recipient is using a diet not prescribed by the center (extraneous to the treatment plan), the user should enter No.
If Yes, complete the following fields:
Patient on oral medication to control blood sugar?: Select Yes, No, or UNK to indicate whether the patient is on oral medication to control blood sugar. This field is required.
Date of medications resumed: Enter the date medications resumed using the standard 8-digit numeric format of MM/DD/YYYY. Date must be after date of birth and before and/or equal to today's date. If unavailable, select the status from the ST field (N/A, Not Done, Missing, Unknown). This field is required.
Patient using diet to control blood sugar: Select Yes, No, or UNK to indicate whether the patient is using diet to control blood sugar. This field is required.
Patient on insulin? Select Yes, No, or UNK to indicate whether the patient is currently on insulin as of the patient status date. This field is required.
If Yes, complete the following fields:
Date insulin resumed: Enter the date insulin resumed using the standard 8-digit numeric format of MM/DD/YYYY. Date must be after date of birth and before and/or equal to today's date. If unavailable, select the appropriate status from the ST field (N/A, Not Done, Missing, Unknown). This field is required.
Average total insulin dosage per day: Enter the average daily total insulin dosage units (units/kg/day) in the space provided. Average daily insulin dose should be a total including all insulin administered in any form per day (short term, long term, by pump, subcutaneous). The insulin dosage units must be between 1 and 1000. If the value is unavailable, select the appropriate status from the ST field (N/A, Not Done, Missing, Unknown). This field is required.
Insulin duration of use: Enter the insulin duration of use (days) for the current dosage in the space provided. If unavailable, select the appropriate status from the ST field (N/A, Not Done, Missing, Unknown). This field is required.
C-peptide value: Enter the c-peptide value in ng/mL. The value must be between 0.00 and 99.90. If unavailable, select the status from the ST field (N/A, Not Done, Missing, Unknown).
Pancreas Transplant Complications: (Not leading to graft failure.)
For each of the complications listed, indicate if the complication occurred prior to the recipient's hospital discharge. Do not select Yes if the complication contributed to failure of the pancreas graft.
Pancreatitis: If the recipient has been diagnosed as having pancreatitis, select Yes. If not, select No. If unknown, select UNK. This field is required.
Anastomotic Leak: If the recipient exhibits signs and symptoms of an anastomotic leak, select Yes. If not, select No. If unknown, select UNK. This field is required.
Abscess or Local Infection: If the recipient exhibits signs and symptoms of abscess or local infection, select Yes. If not, select No. If unknown, select UNK. This field is required.
Pancreas Transplant Complications: Other: If a complication other than those listed occurred, specify the complication in the space provided.
Did patient have any acute rejection episodes between transplant and discharge: If the recipient had any acute rejection episodes between transplant and discharge, select a Yes choice. If not, select No. This field is required. (List of Any Acute Rejection Episodes codes)
Yes,
at least one episode treated with anti-rejection agent
Yes, none
treated with additional anti-rejection agent
No
Immunosuppressive Information
Are any medications given currently for maintenance or anti-rejection: If medications have been given to the recipient for maintenance or anti-rejection during the time between transplant and hospital discharge, or 6 weeks post-transplant if the recipient has not been discharged, select Yes. If not, select No. If Yes, complete the sections below. This field is required.
Definition of Immunosuppressive Medications
For each of the immunosuppressive medications listed, select Ind (Induction), Maint (Maintenance) or AR (Anti-rejection) to indicate all medications that were prescribed for the recipient during the initial transplant hospitalization period, and for what reason. If a medication was not given, leave the associated box(es) blank.
Induction (Ind) immunosuppression includes all medications given for a short finite period in the perioperative period for the purpose of preventing acute rejection. Though the drugs may be continued after discharge for the first 30 days after transplant, it will not be used long-term for immunosuppressive maintenance. Induction agents are usually polyclonal, monoclonal, or IL-2 receptor antibodies (example: methylprednisolone, Campath, Thymoglobulin, or Simulect). Some of these drugs might be used for another finite period for rejection therapy and would be recorded as anti-rejection therapy if used for this reason. For each induction medication indicated, write the total number of days the drug was actually administered in the space provided. For example, if Simulect was given in 2 doses a week apart then the total number of days would be 2, even if the second dose was given after the patient was discharged.
Maintenance (Maint) includes all immunosuppressive medications given before, during or after transplant with the intention to maintain them long-term (example: prednisone, cyclosporine, tacrolimus, mycophenolate mofetil, azathioprine, or Rapamune). This does not include any immunosuppressive medications given to treat rejection episodes, or for induction.
Anti-rejection (AR) immunosuppression includes all immunosuppressive medications given for the purpose of treating an acute rejection episode during the initial post-transplant period or during a specific follow-up period, usually up to 30 days after the diagnosis of acute rejection (example: methylprednisolone, or Thymoglobulin). When switching maintenance drugs (example: from tacrolimus to cyclosporine; or from mycophenolate mofetil to azathioprine) because of rejection, the drugs should not be listed under AR immunosuppression, but should be listed under maintenance immunosuppression.
If an immunosuppressive medication other than those listed is being administered (e.g., new monoclonal antibodies), select Ind, Maint, or AR next to Other Immunosuppressive Medication field, and enter the full name of the medication in the space provided. Note: Do not list non-immunosuppressive medications.
Drug used for induction, acute rejection, or maintenance
Select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).
Steroids (prednisone, methylprednisolone, Solumedrol, Medrol)
Drugs used for induction or acute rejection
Select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).
Atgam
Campath (alemtuzumab)
Cytoxan (cyclophosphamide)
Methotrexate (Folex PFS, Mexate-AQ, Rheumatrex)
Rituxan (rituximab)
Simulect (basiliximab)
Thymoglobulin
Drugs primarily used for maintenance
Select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).
Cyclosporine, select from the following:
Gengraf
Neoral
Sandimmune
Generic cyclosporine
Imuran (azathioprine, AZA)
Leflunomide (LFL)
Mycophenolic acid, select from the following:
CellCept (MMF)
Generic MMF (generic CellCept)
Myfortic (mycophenolic acid)
Generic Myfortic (generic mycophenolic acid)
mTOR inhibitors, select from the following:
Rapamune (sirolimus)
Generic sirolimus
Zortress (everolimus)
Nulojix (belatacept)
Tacrolimus, select from the following:
Astagraf XL (extended release tacrolimus)
Envarsus XR (tacrolimus XR)
Prograf (tacrolimus)
Generic tacrolimus (generic Prograf)
Other drugs
Select the appropriate status from the applicable Status field (Missing, Unknown, N/A, Not Done).
Other immunosuppressive medication, specify:
| File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
| File Title | Pancreas Transplant Recipient Registration_Instructions |
| Author | Alex Garza |
| File Modified | 0000-00-00 |
| File Created | 2022-02-18 |